ArticleBMJ open2024
Prevalence and determinants of TB/HIV coinfection: the double tragedy of infectious disease burden - a 5-year retrospective study in a tertiary health facility in Enugu State, Nigeria.
Article in BMJ open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Evaluation of demographic and co-infection pattern amongst HIV seropositive individuals in a tertiary care centre.Bioinformation · 2026Article
- Tertiary-care management of TB/HIV co-infection in Port Harcourt, Nigeria: A retrospective cohort analysis.PloS one · 2026Article
- Clinico-radiological characteristics and lethality of HIV-tuberculosis coinfection in the Infectiology ward of the Libreville University Hospital, Gabon.Southern African journal of infectious diseases · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo ascertain the prevalence and determinants of tuberculosis (TB)/HIV coinfection in Enugu State Nigeria. STUDY
designA 5-year record-based retrospective study (2018-2022) conducted at a tertiary health facility to identify TB/HIV coinfections.
settingAbout 483 patients treated for TB at the centre were included in the study. PRIMARY OUTCOME MEASURE: The χ
resultsOf the 483 patients with TB treated within the study period (2018-2022), all of them were screened for HIV and 29.0% of them had TB/HIV coinfection. The prevalence of TB/HIV coinfection was highest in 2021 (27.1%). On logistic regression, TB/HIV coinfection was more likely among traders (adjusted OR, AOR 4.932, 95% CI 1.364, 17.839) and students (AOR 2.772, 95% CI 1.014, 7.577). Those diagnosed in 2022 (AOR 0.514, 95% CI 0.272, 0.969) and those who reside in urban areas (AOR 0.594, 95% CI 0.372, 0.949) had lower odds of having TB/HIV coinfection.
conclusionAlmost one-third of all the patients with TB (29.0%) treated at the health facility were HIV coinfected. Occupation of the patients was found to predict TB/HIV coinfection as traders had the highest odds of TB/HIV coinfection when compared with the other occupational groups. Targeted interventions should be geared towards these groups of persons for better prevention and control of both TB and HIV infections in the State.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.